スコポラミンの世界市場：現状分析と予測（2022年～2028年）

世界のスコポラミンの市場規模は、2020年に4億米ドル以上となり、予測期間（2022年～2028年）には約5％のCAGRが見込まれています。世界中で旅行者の数が増加していること、乗り物酔いをする人の増加、慢性疾患による手術の増加は、スコポラミン市場の成長を促進しています。

当レポートでは、世界のスコポラミン市場について調査しており、市場の洞察、市場動向、競合シナリオ、企業概要など、包括的な情報を提供しています。

目次

第1章 市場イントロダクション

• 市場の定義
• 主な目的
• ステークホルダー
• 制限

第2章 調査方法または仮定

• スコポラミン市場の調査プロセス
• スコポラミン市場の調査手法
• 回答者プロファイル

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 スコポラミン市場へのCOVID-19の影響

第6章 スコポラミン市場収益（2020年～2028年）

第7章 市場の洞察：剤形別

• 注射剤
• 錠剤
• 経皮パッチ
• その他

第8章 市場の洞察：流通チャネル別

• 病院薬局
• 小売薬局
• その他

第9章 市場の洞察：地域別

• 北米
  • 米国
  • カナダ
  • その他の北米
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋地域
• 世界のその他の地域

第10章 スコポラミン市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第11章 スコポラミン市場機会

第12章 スコポラミン市場動向

第13章 需要側と供給側の分析

• 需要側分析
• 供給側分析

第14章 バリューチェーン分析

第15章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第16章 会社概要

• Pfizer Inc.
• Baxter International Inc.
• Myungmoon Pharm Co Ltd
• Novartis AG
• Perrigo Company PLC
• Fine Chemicals Corporation
• GSK plc
• Alchem International Pvt. Ltd.
• Phytex Australia Pty Ltd
• Caleb Pharmaceuticals, Inc.

第17章 免責事項

Global Scopolamine Market was valued at more than USD 400 million in 2020 and is expected to grow at a significant rate of around 5% during the forecast period. The global scopolamine market is anticipated to witness an uptick owing to the rising number of people having motion sickness, and growing awareness among the population globally. About 1 in 3 people are considered highly susceptible to motion sickness. Furthermore, American Institute of Stress, 80% of U.S. workers said that they experience stress on the job. Also, Over three-quarters of adult report symptoms of stress, including headache, tiredness, or sleeping problems, as per the American Psychological Association, 2019. This rising number of people having psychological stress is also one of the prominent factors due to which people feel motion sickness which in turn is also increasing the demand for scopolamine drugs among the population. In addition to this, the growing number of travelers across the globe and an increasing number of surgeries due to chronic diseases are also some of the factors contributing to the growth of the market.

Pfizer Inc., Baxter International Inc., Myungmoon Pharm Co Ltd., Novartis AG, Perrigo Company PLC, Fine Chemicals Corporation, GSK plc, Alchem International Pvt. Ltd., Phytex Australia Pty Ltd., Caleb Pharmaceuticals, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with scopolamine.

Insights Presented in the Report:

"Amongst dosage form, transdermal patches category to witness higher CAGR during the forecast period"

Based on dosage form, the scopolamine market is segmented into injectables, tablets, transdermal patches, and others. The transdermal patches scopolamine segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as they are widely for the treatment of motion sickness nowadays. Furthermore, growth in the number of domestic and international travelers and in areas of product launches in the market is also positively influencing the growth of the market.

"Amongst distribution channel, the hospital pharmacies to hold a significant share in the market in 2020"

On the basis of distribution channels, the market is fragmented into hospital pharmacies, retail pharmacies, and others. Among these, the hospital pharmacies to hold a significant share in the market in 2020. This is mainly due to the increasing preference of the patients to avail treatment in hospitals and the easy availability of the medication in hospital pharmacies. However, the online pharmacy segment is expected to witness significant growth owing to the growing penetration of e-pharmacy platforms across the world coupled with increasing awareness regarding services offered by e-pharmacy.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the All-Terrain Vehicle industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, a rising number of surgeries, and an increasing number of travelers in the region. For instance, U.S. domestic travel increased 1.7% in 2019 to a total of 2.3 billion person-trips. Also, Leisure travel accounted for 80% of all U.S. domestic travel in 2019. Furthermore, the presence of key industry players in the region and an increasing number of product launches are also some of the factors contributing to the market growth.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global scopolamine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Scopolamine Market
• 2.2. Research Methodology of the Scopolamine Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SCOPOLAMINE MARKET

6 SCOPOLAMINE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY DOSAGE FORM

• 7.1. Injectables
• 7.2. Tablets
• 7.3. Transdermal Patches
• 7.4. Others

8 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

• 8.1. Hospital Pharmacies
• 8.2. Retail Pharmacies
• 8.3. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 SCOPOLAMINE MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 SCOPOLAMINE MARKET OPPORTUNITIES

12 SCOPOLAMINE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

• 16.1. Pfizer Inc.
• 16.2. Baxter International Inc.
• 16.3. Myungmoon Pharm Co Ltd
• 16.4. Novartis AG
• 16.5. Perrigo Company PLC
• 16.6. Fine Chemicals Corporation
• 16.7. GSK plc
• 16.8. Alchem International Pvt. Ltd.
• 16.9. Phytex Australia Pty Ltd
• 16.10. Caleb Pharmaceuticals, Inc.

17 DISCLAIMER